Dr. Reddys Laboratories (RDY)
(Delayed Data from NYSE)
$81.43 USD
-1.89 (-2.27%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $81.45 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$81.43 USD
-1.89 (-2.27%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $81.45 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth C Momentum C VGM
Zacks News
Dr. Reddy's (RDY) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Dr. Reddy's (RDY) reports better-than-expected fourth-quarter results where both earnings and revenues beat estimates.
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks.com featured highlights Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger
by Zacks Equity Research
Insperity, Microchip Technology, Darden Restaurants, Dr. Reddy's and W.W. Grainger have been highlighted in this Screen of The Week article.
5 Top-Ranked Dividend Growth Stocks to Buy Now
by Sweta Killa
Insperity (NSP), Microchip Technology (MCHP), Darden Restaurants (DRI), Dr. Reddys (RDY) and W.W. Grainger (GWW) could be compelling picks for investors.
Strength Seen in Amphastar (AMPH): Can Its 6.4% Jump Turn into More Strength?
by Zacks Equity Research
Amphastar (AMPH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
U.S. Economy Suffering From Dichotomy: 5 Safe Stocks
by Nalak Das
We have selected five defensive stocks with strong momentum. These are: CAG, COTY, NEE, NJR, RDY.
Zacks.com featured highlights include Dr. Reddys Laboratories, Darden Restaurants, The Interpublic Group of Companies, Microchip Technology and Valero Energy
by Zacks Equity Research
Dr. Reddys Laboratories, Darden Restaurants, The Interpublic Group of Companies, Microchip Technology and Valero Energy are part of the Zacks Screen of the Week article.
COYA, Dr. Reddy's Sign Deal for Proposed Abatacept Biosimilar
by Zacks Equity Research
COYA and Dr. Reddy's enter into a license agreement where the latter will source proposed biosimilar of abatacept biosimilar to Coya to develop and commercialize COYA 302.
5 Top-Ranked Dividend Stocks to Counter Market Volatility
by Sweta Killa
Dr. Reddys (RDY), Darden Restaurants (DRI), Interpublic Group (IPG), Microchip Technology (MCHP) and Valero Energy (VLO) could be compelling picks amid market volatility.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 Generic Drug Stocks to Watch Amid Macro Headwinds
by Sundeep Ganoria
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry persists. New product launches provide some respite to AMPH, RDY and TEVA.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Dr. Reddy's (RDY) Q3 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Dr. Reddy's (RDY) beat earnings and revenues in the fiscal third quarter, driven by growth in the United States and Russian markets.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
TEVA Shares Rise on Broad Support for Opioids Settlement
by Zacks Equity Research
With the required participation from states and local governments, TEVA can now move forward with the nationwide settlement.
New Strong Buy Stocks for January 10th
by Zacks Equity Research
STNE, JD, VSH, MOMO and RDY have been added to the Zacks Rank #1 (Strong Buy) List on January 10 , 2023.
Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Here is how McKesson (MCK) and Doctor Reddy's (RDY) have performed compared to their sector so far this year.
Teva Pharmaceutical Industries Ltd. (TEVA) Stock Jumps 5.5%: Will It Continue to Soar?
by Zacks Equity Research
Teva Pharmaceutical Industries Ltd. (TEVA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.
Doctor Reddy's (RDY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Doctor Reddy's (RDY) closed the most recent trading day at $52.12, moving +0.77% from the previous trading session.
The Zacks Analyst Blog Highlights JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang
by Zacks Equity Research
JD.com, Sigma Lithium, Dr. Reddys Laboratories, MakeMyTrip and Coupang are part of the Zacks top Analyst Blog.
5 Best Emerging Markets Stocks to Buy for 2023
by Urmimala Biswas
Here are five emerging market stocks, JD, SGML, RDY, MMYT and CPNG that are expected to gain enormously in 2023, capitalizing on their growth prospects.
Doctor Reddy's (RDY) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Doctor Reddy's (RDY) closed at $52.85 in the latest trading session, marking a +0.3% move from the prior day.
Doctor Reddy's (RDY) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Doctor Reddy's (RDY) closed at $54.62 in the latest trading session, marking a +0.57% move from the prior day.
Zacks Industry Outlook Highlights Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies
by Zacks Equity Research
Dr. Reddy's, Amphastar Pharmaceuticals and Sol-Gel Technologies have been highlighted in this Industry Outlook article.